Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For the first time, this significant biennial event is held in the United Kingdom, involving on a broad array of investigators and clinicians from across Europe and beyond.

Founded with the vision of the late Dr Samuel Strober, these workshops have served as a catalyst for innovation and collaboration, focusing on overcoming the longstanding challenges of transplant rejection and the complications arising from immunosuppressive therapies.

This year, we are delighted to incorporate discussions on autoimmunity. By expanding the dialogue, we aim to identify intersections between transplantation tolerance and autoimmune regulation. The Sixth International Sam Strober Workshop promises to be an enriching experience, featuring key updates on ongoing trials, interactive discussions, and networking opportunities.

Sunday 24 March 2024

19:00-21:30 - Welcome Reception

Monday 25 March 2024

8:00-9:00 - Breakfast and Registration

9:00-9:15 - Welcome and Introduction

Chimerism Trials

9:15-9:35 - Tatsuo Kawai – MGH Trials

9:35-9:55 - Stephan Busque – Stanford Trials

9:55-10:15 - Dan Brennan – Medeor Therapeutics update

10:15-10:45 - Coffee Break

10:45-11:05 - Alice Bertaina – Chimerism in Paediatric Kidney Transplantation

11:05-11:25 - Joshua Weiner - ITBMed Clinical Trial

11:25-11:45 - Ephraim Fuchs – FCR/ImmunoFree

11:45-12:05 - Jeffrey Veale – UCLA – Delayed Tolerance Trial

12:05-13:05 - Lunch Break

Cell Therapy Trials

13:05-13:25 - James Markmann – Liver Tolerance with Tregs

13:25-13:45 - Qizhi Tang – Insights from the UCSF Trials

13:45-14:05 - Koichiro Uchida – Juntendo University Treg Trials

14:05-14:25 - Thomas Wekerle – Vienna CKBMT + Tregs Trial

14:25-14:45 - Coffee Break

14:45-15:05 – Fadi Issa – TWO Study update

15:05-15:25 – James Mathew – Northwestern Treg trials

15:25-15:45 - Angus Thomson – Pitt DC Trial

15:45-16:05 - Coffee Break

16:05-16:25 – Aurelie Moreau – Nantes DC Trial

16:25-16:45 - Joseph Leventhal – Northwestern CD34 and FCR trials

16:45-17:05 – Ed Geissler – Lessons learned from the ONE Study

17:05-17:25 – Gilbert Fruhwirth – Imaging cellular therapies

Evening - Formal Dinner, Exeter College

 

Tuesday 26 March 2024

8:00-9:00 - Breakfast

Autoimmunity

9:00-9:20 - Piotr Trzonkowski – Diabetes

9:20-9:40 - John Isaacs – Challenges of therapeutic tolerance in autoimmunity

9:40-10:00 - Tim Tree – Biomarkers in T1D trials

10:00-10:20 - Elmar Jaeckel – Quell CAR Tregs in transplant and autoimmunity

10:20-10:40 - Coffee Break

CAR/Next Generation Tregs

10:40-11:00 - Megan Levings – CAR Tregs

11:00-11:20 - Sangamo Therapeutics – STEADFAST

11:20-11:40 - Petra Reinke – Charite Next generation Tregs

11:40-12:00 - Carole Guillonneau – Nantes CD8 Treg Trials

12:00-12:20 - Giovanna Lombardi – Thymus Tregs and novel trials

12:20-13:20 – Lunch Break

Immunosuppression Weaning/Biomarkers & Monitoring

13:20-13:40 - Alberto Sanchez Fueyo – IL-2 Trial

13:40-14:00 - Josh Levitsky – Drug minimisation in liver transplantation (virtual)

14:00-14:20 - Megan Sykes – TCRs and Tolerance

14:20-14:40 - Jake Demetris – Immune Synapse Formation as a Biomarker

Afternoon - Walking Tour – A History of Medicine at Oxford